Figures
Abstract
Superspreading, where a small proportion of a population can cause a high proportion of infection transmission, is well known to be important to the epidemiology of a wide range of pathogens, including SARS-CoV-2. However, despite its ubiquity in important human and animal pathogens, the impact of superspreading on the evolution of pathogen virulence is not well understood. Using theory and both deterministic and stochastic simulations we examine the evolution of pathogen virulence under a range of different distributions of infection transmission for the host. Importantly, for many pathogens, superpreader events may be associated with increased tolerance to infection or asymptomatic infection and when we account for this superspreading selects for higher virulence. In contrast, in animal populations where highly connected individuals, that are linked to superspreader events, also have fitness benefits, superspreading may select for milder pathogens. In isolation, the transmission distribution of the host does not impact selection for pathogen virulence. However, superspreading reduces the rate of pathogen evolution and generates considerable variation in pathogen virulence. Therefore, the adaptation of an emerging infectious disease, that exhibits superspreading, is likely to be slowed and characterised by the maintenance of maladaptive variants. Taken as a whole, our results show that superspreading can have important impacts on the evolution of pathogens.
Author summary
The impact of infectious disease can vary from individual to individual. Superspreader events, where a few individuals cause a high proportion of infections, are critical to the spread and outbreak size of a wide range of important infectious diseases of humans and animals. Superspreading events and pathogen evolution, were important features of the Covid-19 pandemic, highlighted by the succession of dominant strains during the pandemic. There is a clear need to understand how superspreader events will affect the evolution of pathogens, in particular how the level of virulence (the additional mortality due to the infection) will evolve. In this study we use mathematical models to show that superspreading reduces the rate of pathogen evolution and generates considerable variation in pathogen virulence. Therefore, the adaptation of an emerging infectious disease, that exhibits superspreading, is likely to be slowed and characterised by the maintenance of maladaptive variants. Importantly, for many pathogens, superpreader events may be associated with increased tolerance to infection or asymptomatic infection, and when we account for this, superspreading selects for higher virulence. Our results show that superspreading can have important impacts on the evolution of pathogens.
Citation: O’Neill X, White A, Northrup GR, Saad-Roy CM, White PS, Boots M (2025) Superspreading and the evolution of virulence. PLoS Comput Biol 21(10): e1013517. https://doi.org/10.1371/journal.pcbi.1013517
Editor: Edward M. Hill, University of Liverpool, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
Received: April 28, 2025; Accepted: September 13, 2025; Published: October 9, 2025
Copyright: © 2025 O’Neill et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Please use the following link to access example code in MATLAB2023b: https://github.com/XanderONeill/Superspreading_and_the_evolution_of_virulence.
Funding: X.O. and A.W. were supported by the Biotechnology and Biological Sciences Research Council (BBSRC) EEID research grant BB/V00378X/1. M.B., G.R.N., and P.S.W. were supported by National Science Foundation NSF-DEB-2011109 EEID research grant. C.M.S.-R. gratefully acknowledges funding from the Miller Institute for Basic Research in Science of UC Berkeley via a Miller Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Recent epidemics have emphasised the importance of infectious disease to human health, agricultural and natural wildlife systems [1–4]. It is now recognised that the management of epidemic and endemic infection requires well-developed theory, not only on the ecology/epidemiology, but also on the evolution of pathogens [5,6]. The SARS-CoV-2 epidemic has further emphasised a key feature of many important pathogens, that there is considerable heterogeneity between individuals in infection transmission levels and disease severity [7–9]. In particular, superspreader events, where some individuals infect a considerably higher proportion of the population than an average individual [3,7,10,11], are critical to the epidemic outcome. As the proportion of the population that are superspreaders increases, both the likelihood of disease extinction and size of infectious outbreaks also increase [10–14]. In the context of evolution it has been shown that superspreading can suppress the invasion of new strains and may slow disease adaptation [13,14]. However, the impact of superspreading on the evolution of virulence (defined throughout as the increase in mortality due to infection) is unclear and given both the ubiquity of superspreading and the central role of the evolution of pathogens to their epidemiological impact this is an important knowledge gap [12].
Understanding the evolution of pathogen virulence and transmission is important for understanding emergent disease outcomes, for the development of disease management strategies, and to assess the burden of infectious disease in natural populations [15,16]. Much of our current knowledge is based on the results of theoretical studies that make predictions on how virulence may evolve under a wide range of conditions [15]. This well-developed theory commonly assumes a saturating trade-off between transmission and virulence and makes general predictions [17–19], including how an increase in host mortality (and therefore a reduction in host lifespan) selects for increased transmission and virulence [15,18], a result that holds when the host mortality increase is due to predation [20], the host immune response [21], or culling [22]. There is also theory on the impact of host population structure on the evolution of virulence, showing that as spatial contact structure changes, from global to highly local, virulence typically evolves to a lower level [23–26].
The effect of host heterogeneity on the evolution of pathogen virulence has been analysed in systems that consider two distinct host types [27,28], when infection control can partition a single host based on infection risk [15,29], and through control with imperfect vaccines [30,31]. When a pathogen can infect two host types and pathogen virulence in each host was linked via a trade-off, theory has shown that pathogen evolution in a heterogeneous host population may evolve to specialise for one of the two host types at the cost of losing its specialisation for the other type [27]. With infection control, host heterogeneity can have an impact on pathogen evolution when vaccination is targeted at a more vulnerable subpopulation. Transmission then becomes concentrated on the unvaccinated subpopulation which can change the evolved level of virulence compared to uniform vaccine coverage [15,29]. Similarly imperfect vaccines lead to heterogeneity between vaccinated and unvaccinated hosts and can select for an increase or decrease in virulence depending on the pathogen mechanisms that the vaccine targets [30,31]. There is also theory on the coevolution of sociality and pathogen virulence that assumes variation across hosts in contacts and transmission [32,33], but these studies do not assess pathogen evolution for different contact distributions. Importantly, the variation between individuals in terms of infection transmission is often related to other disease characteristics [34,35], in particular, superpreader events may be associated with increased tolerance to infection or asymptomatic infection, as observed in the COVID-19 pandemic [7–9]. As such, while previous studies have highlighted that various forms of host heterogeneity can play a role in determining virulence evolution, a clear focus on how superspreading will affect the evolution of virulence is still required.
Previous work has shown that superspreading events can suppress the emergence of new pathogen strains [13] and that superspreading, represented as a change in the number of host contacts, has no effect on virulence evolution in classical SI models [36]. However, the impact on virulence of a range of contact/transmission structures, that characterise increasing levels of superspreading, has not been examined in detail. Moreover, transmission heterogeneity and in particular, superspreading, may be associated with individual level variation in other host characteristics including host natural mortality, increased disease-induced mortality (vulnerability), or decreased disease-induced mortality (tolerance) [34,35], and the impact of these associations has not been explored. Using both deterministic and stochastic model frameworks, we address these knowledge gaps by examining the impact of a range of contact/transmission structures and how the association between superspreading and other host and pathogen characteristics impact the evolution of virulence. In line with previous theoretical studies that examine pathogen evolution (see [15]), we will develop a general model framework for an endemic infectious disease system and use this to test and explain how changing from a homogeneous to an increasingly heterogeneous transmission distribution for the host will effect pathogen selection for virulence. Our results show how superspreading impacts the rate of evolution, the diversity of evolved pathogen strains, the persistence of maladaptive variants, and importantly the evolved level of pathogen virulence and transmission.
Methods
In a seminal paper on the epidemiological impacts of superspreading, Lloyd-Smith et al. (2005) [11] assumed variation in infection transmission between individuals and confronted models with data for a wide range of important human infectious diseases. They showed how superspreading can be captured by a gamma distribution that represented the individual level variation in the number of secondary cases of infection. We follow this established approach and represent heterogeneity by a gamma distribution that represents variation in infection transmission across host individuals [11]. The shape parameter for the gamma distribution governs the transmission distribution for the host (Fig 1), which ranges from homogeneous (all host individuals have the same level of transmission), to superspreading (a few host individuals have a high level of transmission, and most individuals have a low level of transmission). Importantly, we assume that the different transmission distributions have the same mean level of transmission.
As k increases the transmission distribution transitions from superspreading to homogeneous. The red line shows the exact gamma distribution and the blue bars our discretised version used in simulations. The mean transmission level is the same in all distributions. In (b) we highlight possible transmission events from an infected individual (red) that can infect individuals (yellow) from a pool of susceptible individuals (green). We capture superspreading, where an individual may infect few individuals (top left) or many individuals (top right), and a homogeneous transmission distribution where an infected individual always infects the same number of susceptible individuals (bottom left and right). In (c) we show a schematic of our model (Eq 1) highlighting how infection from an infected of type Ij of a susceptible of type Si leads to an infected of type Ii. Fig 1 was produced by the authors, with Fig 1a obtained using MATLAB 2023b, and Fig 1b and 1c designed and produced by XO using Adobe Illustrator.
To assess the impact of superspreading on pathogen evolution we extend a classical susceptible-infected (SI) epidemiological model [37,38] where a susceptible, S, can become infected, I, through direct contact. The susceptible and infected classes are partitioned into nc host types based on their transmission level, with an individual of host type i having transmission level ci. The model for the population density of individuals of host type i is as follows:
Here, denotes the total population density, b denotes the maximum birth rate, and d(ci) denotes the natural, non-disease related, death rate for type i (with transmission level ci). Note, we initially assume d(ci) = d and so is independent of the transmission level of the host. Later we relax this assumption. The parameter q represents the population’s susceptibility to crowding and is set such that the population size is equal to its carrying capacity, N = NK, in the absence of infection. When d(ci) = d this implies q = (b−d)/NK. When
varies with ci then
.
We assume a proportion, pi, of all births occur into susceptible class, Si. This proportion follows a truncated, discrete, gamma probability distribution function with shape parameter k and mean , following the scale-shape definition of a gamma distribution,
, where
. Here
is the average level of transmission for the host and this remains fixed for all transmission distributions. We truncate the probability distribution between 0 and 100, resulting in nc = 100 classes. We discretise the range [0,100] into unit intervals so that we can have finite classes in the models. Each ci takes the expected value of the probability distribution within the respective unit interval. We consider a range of gamma distributions, with the restriction that
, and where the transmission distribution for the host can range from homogeneous (large k), to heterogeneous (small k). This framework characterises distributions with an increasing probability of superspreading as k decreases (Fig 1).
We assume density-dependent infection transmission with the transmission coefficient for an infected individual of type j infecting a susceptible individual of type i given by . Here β is the transmission component controlled by the pathogen, the transmission level ci equates to the susceptibility of host type i, and cj to the infectivity of host type j. Our default assumption is that a superspreader will have high susceptibility and high infectivity, and this emerges naturally when heterogeneity in transmission occurs through host contacts. However, other mechanisms that lead to heterogeneity in transmission in the host, particularly those that have a biological basis, may impact either susceptibility or infectivity only and it is critical to distinguish between superspreading as a consequence of social behaviour/contact rate heterogeneity, and superspreading rooted in biological factors [34]. We account for this by adjusting the transmission coefficient to
if there is heterogeneity in host susceptibility only, and to
if it impacts infectivity only. This set-up allows us to consider different underlying mechanisms that could lead to heterogeneity in ci, such as behavioural mechanisms that lead to variation in host contacts or physiological mechanisms that may lead to variation in host vulnerability or tolerance [34,35] and highlights the flexibility of the transmission term to capture several different aspects of superspreading.
Infected individuals incur disease-induced mortality (virulence) at rate . Here, α is the contribution to virulence set by the pathogen. We initially assume the host component of virulence is independent of host type h(ci) = 1. If we instead assume that host transmission is related to host vulnerability, then hosts with high susceptibility to infection incur additional disease induced mortality, represented by taking h(ci) to be an increasing function of ci. If hosts with high infectivity are more tolerant of the infection, then h(ci) is a decreasing function of ci [39–42]. Parameter descriptions are detailed in Table 1.
Note, our model framework could be easily adapted to encompass other epidemiological systems. We currently consider a range for pathogen virulence which is high (, see Table 1), and use an SI framework. However, we confirm our findings when virulence is low (
), and in other model frameworks, notably SIRS (which encompasses SIR and SIS), and for frequency-dependent transmission (see Sects S1.1 and S4, in S1 Text). Due to the general nature of our model framework, our findings are applicable to a wide range of real systems, including wildlife systems where infection is fatal and virulence is high (African Swine Fever, Chytridiomycosis, Devil Facial Tumour Disease, Marek’s disease, Myxomatosis, Parvovirus, Squirrelpox), and for many wildlife and human infections from which the host can recover and exhibit immunity [43–45].
Evolution of virulence
This model framework (Eq 1) can be used to simulate the epidemiological dynamics for different transmission distributions (determined by k). In this study we will examine how pathogen virulence will evolve under a range of different distributions for infection transmission of the host (that is, for each k we examine how α evolves). We utilise three different modelling techniques to model the evolutionary process: adaptive dynamics [46,47], deterministic simulations, and stochastic simulations. We use adaptive dynamics to provide analytical expressions for the evolutionarily singular strategy (ESS) for virulence. We use this approach specifically when d(ci) = d and h(ci) = 1, as here analytic expressions are tractable. We use deterministic simulations to illustrate the analytical findings, and to determine ESS virulence for scenarios where the adaptive dynamics analysis is intractable (when d(ci) and h(ci) are not constant). We use stochastic simulations to provide information on the rate of evolution to the ESS and the variation in virulence.
All three modelling techniques include a mutation process that allows new strains of the pathogen (with different values of α) to emerge and potentially replace the current, resident, pathogen strain. Throughout, and in line with previous studies [15,17,18], we assume that there is a trade-off between β and α such that benefits to the pathogen in terms of increased transmission are bought at a cost of increased virulence [17–19]. Mathematically this means where
and
[48]. This ensures virulence evolves to an evolutionarily stable strategy (ESS). For the deterministic and stochastic simulations we require an explicit expression for the trade-off between transmission and virulence [22,49]. This takes the following form:
where denote the minimum and maximum values for β, respectively,
denote the minimum and maximum values for α, respectively, and a represents the curvature of the trade-off function (see S2 Fig).
Adaptive dynamics.
Adaptive dynamics assumes a separation of epidemiological and evolutionary time scales such that the epidemiological dynamics have reached a dynamic attractor before mutation of a new pathogen strain is considered [46,47]. When mutation occurs, a mutant strain, with small phenotypic variation from the resident strain, emerges (at low density) and in our study competes with the established resident strain that is at its endemic steady state. The success of the mutant strain depends on its fitness (its long-term growth rate). If the fitness of the mutant strain is negative it will die out. If the fitness of the mutant strain is positive the mutant strain can invade and replace the resident strain, to become the resident itself. Adaptive dynamics considers multiple steps of this mutation and replacement process until the pathogen converges to an ESS.
Deterministic simulations.
To simulate the adaptive dynamics process we split the infected classes into pathogen strains based on their virulence (and transmission), with strains split uniformly across the interval
. A strain z, has virulence,
and pathogen transmission factor
. This requires extending Eq (1) to include
pathogen strains that include the density of hosts of type i that are infected with pathogen strain z. The extended model is as follows:
We use the parameter values stated in Table 1 which are a general parameter set chosen to ensure the system exhibits a stable, positive, endemic steady state for all pathogen strains. We select an arbitrary initial pathogen strain, z = 31 (and so with corresponding
) and initial total densities of S = 151 and I = 584 (the endemic steady state densities when
), which are split for each host class i based on probabilities pi. We then numerically solve Eq (3) for a fixed time, te. This allows the epidemiological dynamics to approach the endemic steady state for that particular pathogen virulence/transmission level. A mutant pathogen strain is then introduced, at low infected density, with a pathogen virulence level close to the current resident strain (the mutant strain is selected as either the strain directly above or below the resident strain, with equal probability). The population dynamics are numerically solved for a further time, te, to allow the epidemiological dynamics to approach the steady state, where either the mutant strain dies out or the mutant replaces the resident strain. This procedure is then repeated, and allows the pathogen to evolve to the ESS,
. These simulation methods have been successfully used to approximate the adaptive dynamics process [46,48], but it should be noted that in this approximation the epidemiological dynamics may not necessarily reach their steady state before a new mutation arises. In this way, the ecological and evolutionary time scales are not strictly separated, as assumed in adaptive dynamics theory.
Stochastic simulations.
We relax the assumptions of adaptive dynamics by considering a stochastic, individual based model of Eq (3) where susceptible, S, and infected, I, populations levels take integer values. As in the deterministic simulations, we use a trade-off between pathogen virulence and transmission (see Eq 2), the parameter values outlined in Table (1), and our default assumption on heterogeneous transmission (that an individual with high susceptibility would also have high infectivity). The key differences between the stochastic simulations and the deterministic simulations are that births are now individual events that occur with probability pi to a specific host type (rather than proportionately to all host types), and that mutations now occur with a small probability, , whenever an infection event occurs (rather than once the population has approached its endemic steady state). The mutant strain is selected as either the strain directly above or below the strain of the infecting individual, with equal probability. Simulations were undertaken using a Gillespie algorithm [50,51] (continuous-time Markov chain), where a specific individual event occurs at random according to the relative transition rates for each event (see Table 2). The population classes and transition rates are updated after each event, and the time between events was taken from an exponential distribution with rate equal to the sum of the transition rates. Notably, the probabilistic and individual based nature of these simulations can result in the stochastic fade-out of pathogen strains.
In addition, we assume that infection can lead to mutation to a neighbouring pathogen strain with probability . To determine all the possible transition events, it is necessary to calculate the transition rates for all host types i and for all possible infection interactions for host type i.
Results
Transmission level of the host is independent of other host characteristics
In our model set-up infection transmission of the host is independent of other host characteristics when h(ci) = 1 and d(ci) = d. Using adaptive dynamics we assess how virulence will evolve by determining the fitness of a mutant strain of a pathogen (with parameter ). We determine conditions that allow the mutant pathogen strain to invade a population with a resident, endemic, pathogen strain (with parameter
). In line with Van Baalen (2002) [36] it can be shown that the fitness of the mutant strain is positive if the following condition is satisfied (see Sect S1 in S1 Text for further details):
Therefore, any mutant strain that satisfies Eq (4) will replace the resident strain and the pathogen evolves a level of virulence, , that maximizes
, which is the optimal strategy [52]. This is independent of the transmission level of the host (independent of ci) and so when h(ci) = 1 and d(ci) = d pathogen virulence will evolve to an ESS at
for all transmission distributions of the host. Note, we show the same analysis for an SIRS model structure with either density-dependent or frequency-dependent transmission in Sect S1 in S1 Text. Again we find that
is independent of the transmission level of the host.
We use deterministic simulations to illustrate the adaptive dynamics results. The deterministic simulations indicate that the pathogen evolves to the same level of virulence for different transmission distributions for the host (Fig 2a). This confirms the adaptive dynamics analysis and indicates that the deterministic simulations provide a robust method for determining ESS virulence.
In (a) and (b) we show the evolution of pathogen virulence over time under different transmission distributions. In (a) we show the deterministic simulations and (b) we show the stochastic simulations (and note the vertical axis is different for k = 0.2 compared to k = 1 and k = 10). In (c) we show the proportion of susceptible individuals in each transmission class, ci and (d) the proportion of infected individuals in each transmission class. All proportions are shown at the evolutionary stable level of pathogen virulence, , in the deterministic simulations. The mean level of transmission,
, is also shown for each distribution. The variance in α over the last 1000 time points of the stochastic simulations is as follows: k = 0.2,
; k = 1,
; k = 10,
. Parameters are taken from Table 1.
Rate of evolution and variability in virulence
Under the stochastic framework, we confirm previous results, that pathogen virulence evolves to and that this is not affected by the transmission distribution of the host (Fig 2b). However, the rate at which virulence evolves and the variability in virulence is different for different transmission distributions (Fig 2b). In particular, for heterogeneous transmission distributions that can represent superspreading, the rate of evolution to
is slowed and the variability in virulence is increased. Under superspreading, the proportion of hosts with high transmission is small, the infected population has a higher proportion of hosts that had high susceptibility and have high infectivity, than the susceptible population that has a higher proportion of hosts with low susceptibility (see Fig 2c and 2d and the reported average level of transmission of the host,
). Since mutation occurs upon infection of a susceptible host, the mutation is likely to reside in a host that had low susceptibility and therefore low infectivity. This means the mutation either spreads slowly or fades-out due to stochastic effects, and explains why the rate is reduced and variability is increased when progressing towards the evolutionarily stable level of virulence,
. Therefore, our first key result is that superspreading per se does not impact the long-term evolution of pathogen virulence, but it slows adaptation and generates diversity.
We find that the increase in variation in virulence and reduction in the rate of adaptation as heterogeneity increases holds when we consider an SIRS model framework (S1 Fig) and different transmission terms that depend on susceptibility and infectivity, susceptibility only, or infectivity only (S3 Fig). When heterogeneity applies to infectivity only (a transmission term of ) then all individuals are equally susceptible, but only a few of the individuals that become infected will have high infectivity and so most mutations occur in individuals with low infectivity. This slows the rate of evolution to
and increases variability in virulence compared to the case with homogeneous transmission (S3b and S3d Fig). When heterogeneity applies to susceptibility only (
) then individuals with higher susceptibility are more likely to become infected and therefore the remaining susceptible population will have reduced (less than average,
) susceptibility. This reduced susceptibility means that when a mutation occurs upon infection the infected individual with the mutant strain will have a reduced chance of causing onward infection, compared to when there is a homogeneous transmission distribution. This, again, reduces the rate of evolution to
and increases variability in virulence (S3c and S3d Fig).
Transmission level of the host is correlated with other host characteristics
We also consider scenarios where infection transmission is associated with other host characteristics, including host lifespan, tolerance to infection, and vulnerability to infection. Whilst determining the fitness of the mutant strains is possible, the analytical expressions for the fitness function and for ESS virulence are complex and do not provide tractable information. Therefore, we find ESS virulence using deterministic simulations and stochastic simulations.
High contact levels increase host lifespan.
Individuals with many contacts may gain fitness benefits, exemplified by the observation that an animals sociability can increase access to survival-related information [53,54]. This increased access can then lead to a reduction in non-disease related mortality (in line with [32,33]). To represent this, we assume ci represents the contact level for hosts of type i and that d(ci) is a decreasing function of ci, with (Fig 3b). In this scenario, we find pathogen virulence decreases as the contact distribution for the host changes from homogeneous to superspreading (Fig 3a). Under superspreading hosts with high contact levels make the greatest contribution to transmission (see S4 Fig), and these hosts have a longer lifespan. In line with previous theory, when overall host lifespan increases, the parasite will reduce virulence [15,18].
(a) The evolved level of pathogen virulence, , for different transmission distributions for the host (characterised by changes in k), and with rates of host natural death, d(ci), linked to host transmission level, ci. (b) The function d(ci) where the host death rate decreases with increases in host transmission level (increased connectivity). Results are obtained from deterministic simulations using parameters as in Fig 2 and the function
.
Superspreading due to variation in tolerant individuals.
Variation in the transmission of infection often arises due to differences in tolerance to infection across the host population [39,40,55], as highlighted by the classic example for typhoid [56]. Here, superspreaders have high pathogen loads but are tolerant, showing few signs of disease, and therefore cause a disproportionate number of transmission events [7,10,11]. This implies that h(ci) is a decreasing function of ci (Fig 4b). Here, we find that pathogen virulence increases as the transmission distribution for the host changes from homogeneous to superspreading (Fig 4a). Under superspreading, a greater proportion of infected hosts are tolerant since they have reduced mortality when infected (see S5 Fig). This reduces the cost of virulence for the pathogen and therefore drives an increase in virulence and transmission. Thus, a key result is that if tolerance underlies superspreading it will select for higher virulence.
(a) The evolved level of pathogen virulence, , for different transmission distributions for the host (characterised by changes in k), and with the function h(ci), linked to host transmission level, ci. (b) The function h(ci) where increases in ci lead to increased tolerance (a decrease in h(ci)). (c) The function h(ci) where increases in ci lead to increased vulnerability (a increase in h(ci)). Results are obtained from deterministic simulations using parameters as in Fig 2 and the functions (b)
and (c)
.
While it may be reasonable to assume that tolerant superspreaders are more infective, this may not imply that they are also more susceptible to infection [8,34]. Therefore, we repeat our analysis under the assumption that susceptibility is constant (at ) and therefore the transmission distribution for the host captures the variation in infectivity of the host and the link between highly infective hosts and tolerance. Under these assumptions we again find that pathogen virulence increases under a superspreading distribution (S6 Fig).
Superspreading due to variation in vulnerable individuals.
Conversely, if increases in transmission levels for hosts arise due to increased host vulnerability that manifest as a reduction in host tolerance to infection [39,40,55], then h(ci) is an increasing function of ci (Fig 4c). We assume vulnerable hosts will have high susceptibility, high infectivity, and increased disease-induced mortality. We find that the evolved level of pathogen virulence decreases as the transmission distribution of the host changes from a more homogeneous to a heterogeneous distribution (Fig 4a and S7 Fig). Under heterogeneous transmission, the hosts with high transmission (high ci) are more easily infected. These hosts have increased disease-induced mortality (high h(ci)), which increases the cost of virulence to the pathogen. To compensate, the pathogen evolves to reduce the component of virulence under its control (a reduction in ).
Discussion
In order to understand the implications of superspreading on the evolution of pathogens we have developed a general mathematical framework that examines the evolution of pathogen virulence under a range of different distributions of infection transmission for the host and its relationship with other host and pathogen characteristics. Following established epidemiological theory, we characterise infection transmission for the host by a gamma distribution [11] and adjust the shape parameter to alter the transmission distribution from homogeneous to superspreading. In line with previous studies that consider classical SI model frameworks, when infection transmission for the host is independent of other host characteristics, we find that superspreading does not affect the evolutionarily stable level of virulence [32,36], but it does have an important impact on the rate of evolution to the ESS [13,14]. We show that this result extends to other model frameworks (SIS,SIR,SIRS) and holds when transmission is density-dependent or frequency-dependent. By considering stochastic simulations for the long-term evolution of virulence, our work highlights that superspreading can also lead to increased variation in virulence. If there is a link between the transmission level of the host and host mortality, we show that superspreading can have a range of impacts on the selection for virulence. In particular, superspreading may arise due to increased tolerance to infection or asymptomatic infection, such that the disease-induced death rate is reduced. In this case, selection for pathogen virulence increases as the transmission distribution for the host changes from homogeneous to superspreading. In contrast if high levels of transmission by the host are associated with a decrease in non-disease mortality or an increase in disease mortality, the evolved level of pathogen virulence will decrease as the transmission distribution for the host changes from homogeneous to heterogeneous. It is well known [11] that the transmission of many infectious diseases can be characterised by superspreading, and our work shows that this can have important implications for the evolution of pathogen virulence.
The evolutionary implications of superspreading can be understood through its impacts on the epidemiological dynamics. We found that a general consequence of superspreading is that the rate of evolution is reduced and the variation in levels of virulence is increased. These effects arise because as the transmission distribution for the host transitions from homogeneous to superspreading, there is an increase in the proportion of infected individuals that have high transmission levels and/or susceptible individuals that have low transmission. Lloyd-Smith et al. (2005) [11] showed that both theory and data indicated that superspreading leads to less frequent but more pronounced outbreaks of infection. The reduction in outbreak frequency emerges because the initial infection is likely to occur in a susceptible host with a low transmission level, and hence the infection may suffer stochastic extinction. The ability of new strains to invade an established, endemic strain has been shown to be linked to pathogen emergence [12–14]. Moreover, it has been shown that superspreading can reduce the chance of an emergence event and so would be expected to slow the rate of adaptation of a pathogen [13,14]. In this study we examine the long-term evolutionary dynamics of the pathogen (we consider multiple emergence events). Under superspreading dynamics, a mutant pathogen strain is likely to emerge, on average, in an individual that has a low transmission level and is therefore more likely to suffer stochastic extinction. Thus, repeated mutation events may be required before the mutant strain is selected for, and this leads to a reduced rate of evolution towards the ESS under superspreading. One of our key results is that superspreading leads to increased variation around the optimal strain. This suggests that the adaptation to its new host of an emerging pathogen that shows high levels of superspreading, may generate and maintain multiple maladapted variants (while evolving to and subsequently around the optimal strategy), which could be more virulent than is optimal in the long-term. Our findings and the interpretation of our findings for an SI model with high underlying virulence extend to example systems with low underlying virulence (S8 and S9 Figs) and to an SIRS model framework. As a whole, this agreement highlights the utility of using general models to understand the biological processes that drive the evolutionary outcomes, since this understanding can often be extended to a wider range of scenarios and systems. Our results that consider different distributions for infection transmission for the host have parallels with results from population genetics, where a reduced effective population size can increase the chance of drift [57]. Read and Keeling (2003) [58] showed that evolutionary change is slower and more variable for a spatial network, than for a comparable mean-field framework, since the network was influenced by the local epidemiology, that can lead to increased extinction of strain lineages, but also because the network models have fewer connections than the mean field framework [58]. The transmission distributions we consider all have the same mean level of connections, and the reduced rate of evolution and increased variability emerge due to the impact of superspreading on the epidemiological dynamics, where mutations arise in individuals with low transmission levels and so have a high chance of stochastic extinction (low chance of emergence [13,14]).
A key result from our study is that the transmission distribution of the host can influence the evolution of virulence when transmission is associated with tolerance to the disease that a pathogen causes. It is likely that tolerant or asymptomatic individuals will, on average, cause more transmission events due to their lack of symptoms and could therefore drive superspreader events [7,10,11,34]. Tolerance to pathogens is an important defence mechanism that reduces the harm that infection causes the host potentially lowering the mortality effect of infection [42,55,59]. Hosts that are more tolerant, live longer, leading to an increase in the infectious period and pathogen prevalence in the population and tolerance has been shown to select pathogens for higher replication rates, and therefore higher pathogen transmission and virulence in non-tolerant hosts [39,40,55,60]. This explains our result that when hosts with high infectivity are more tolerant the pathogen will evolve higher virulence under superspreading. Similar mechanisms lead to selection for higher intrinsic virulence in response to imperfect vaccines that reduce the within host growth rate of the pathogen [30,31] and so our work emphasises how these established theoretical results can be viewed in a new context of superspreading. Our result provides further support for surveillance and testing during infectious outbreaks, and for targeted treatment, since asymptomatic (tolerant) individuals may be responsible for an increase in the incidence of infection [11,34,61,62]. Our study shows that they may also select for more virulent pathogen strains.
Previous studies that have examined how host contact rates may affect the evolution of virulence have generally assumed host contact to be independent of host survival [17,19,63]. Although high host contact levels typically increase the risk of infection, evidence from wildlife systems suggests that sociability has benefits [53,54]. For example, social information can provide individuals with knowledge about resources or environmental conditions, which can reduce host mortality. Ravens, for instance, share information about the location of carcasses with conspecifics [64], and matriarchs of African elephant herds share information about danger and resources with the group [65]. Bonds et al. (2005) [32] showed that when an increase in contact rates can reduce non-disease mortality, the associated increase in host lifespan can indirectly select for lower pathogen virulence [32,33]. This is in line with the general result that indicates that an increase in host lifespan can lead to the evolution of reduced virulence [18]. Our study builds on these insights by examining the evolution of virulence under different host contact distributions (with the same mean contact level) where individual hosts with high contact levels have a fitness benefit in terms of reduced natural mortality. We demonstrate that altering transmission distributions toward superspreading alters contact patterns within susceptible and infected populations, reshaping the epidemiological dynamics and leading to selection for lower pathogen virulence. While there are few natural examples directly illustrating how contact distribution affects virulence, studies in socially structured wildlife populations suggest that transmission dynamics in these systems mirror our models assumptions. For example, superspreader events in vampire bat colonies play a crucial role in rabies transmission [66]. Superspreading bats are socially central and thus may benefit from better health via social grooming and foraging behaviours, which thus may prolong the infectious period and favour the evolution of lower virulence. Similar dynamics exist in tuberculosis spread in both African buffalo [67] and meerkats [68], where social support in highly connected (and thus superspreading) individuals may reduce stress and prolong infection. These cases suggest that in animal populations superspreading often occurs within social structures, creating correlations between transmission and fitness that aligns with our models predictions. Together, these examples and our findings illustrate that social structure in animal populations can influence the evolution of virulence, providing real-world context for the implications of superspreading on pathogen evolution.
We present a general framework for assessing how superspreading influences the evolution of pathogen virulence. Our work emphasizes the importance of including epidemiological dynamics when determining the evolution of pathogen characteristics, since our evolutionary results are direct consequences of changes in these dynamics. We acknowledge that there are many other assumptions and models scenarios that could be tested and note that our methods could be extended in future work to consider the impacts of superspreader events under new contexts. This could include exploring the impact of heterogeneous contact rates on the evolution of virulence in explicitly spatial settings, to tailor the model framework to specific infectious disease systems or to examine how the level of heterogeneity in pathogen transmission may itself evolve. The risk of epidemics in human, agricultural and wildlife systems is intensifying [3], and therefore our findings have important consequences for understanding the risks from rapidly evolving, superspreading, pathogens.
Supporting information
S1 Text. The supplementary material contains the following sections: S1 Adaptive dynamics analysis when transmission is independent of other host characteristics, S2 Trade-off function, S3 Other deterministic and stochastic model simulations, and S4 Lower levels of pathogen virulence.
https://doi.org/10.1371/journal.pcbi.1013517.s001
(PDF)
S1 Fig. The evolution of pathogen virulence over time under an SIRS model framework and under different transmission distributions.
The mean level of transmission across all simulations, , is shown for each distribution (blue thicker line). The additional parameters (
,
) are chosen to be similar to the maximum virulence,
, and the trade-off parameters are adjusted such that the pathogen persists, with an
across all simulations:
. All other parameters are taken from Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s002
(EPS)
S2 Fig. Graphical representation of the transmission-virulence trade-off function (Eq 3 in the main text).
https://doi.org/10.1371/journal.pcbi.1013517.s003
(EPS)
S3 Fig. Stochastic simulations of the evolution of pathogen virulence over time when infection transmission for the host is independent of other host characteristics.
In (a)-(c) hosts have a superspreader/heterogeneous distribution (k = 0.2) where in (a) transmission depends on susceptibility and infectivity (), in (b) transmission depends on infectivity (
) and in (c) transmission depends on susceptibility (
). In (d) hosts have a more homogeneous distribution (k = 10) and transmission depends on susceptibility and infectivity (
). Note, the vertical axis is different for (a) to (c) compared to (d). Parameters are the same as in Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s004
(EPS)
S4 Fig. The evolution of virulence when contacts are linked to host survival.
In (a) and (b) we show the evolution of pathogen virulence over time under different transmission distributions. In (a) we show the deterministic simulations and (b) we show the stochastic simulations. In (c) we show the proportion of susceptible individuals in each transmission class, ci and (d) the proportion of infected individuals in each transmission class. All proportions are shown at the evolutionary stable level of pathogen virulence, , in the deterministic simulations. The mean level of transmission,
, is also shown for each distribution. The simulations are for a function (
) that shows a decrease in natural mortality for hosts that have high transmission, as in Fig 3. Other parameters are taken from Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s005
(EPS)
S5 Fig. The evolution of virulence when infection transmission for the host is linked to tolerance.
In (a) and (b) we show the evolution of pathogen virulence over time under different transmission distributions. In (a) we show the deterministic simulations and (b) we show the stochastic simulations. In (c) we show the proportion of susceptible individuals in each transmission class, ci and (d) the proportion of infected individuals in each transmission class. All proportions are shown at the evolutionary stable level of pathogen virulence, , in the deterministic simulations. The mean level of transmission,
, is also shown for each distribution. The simulations are for a function (
) that shows an increase in tolerance for hosts that have high transmission, as in Fig 4. Other parameters are taken from Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s006
(EPS)
S6 Fig. The evolution of virulence when infectivity is linked to tolerance (increases in infectivity lead to increased tolerance) and when susceptibility is constant (at
) for all hosts.
The evolved level of pathogen virulence, , is shown for different transmission distributions (characterised by changes in k). Results are obtained from deterministic simulations using parameters as in Fig 2 and the function (
).
https://doi.org/10.1371/journal.pcbi.1013517.s007
(EPS)
S7 Fig. The evolution of virulence when transmission is linked to vulnerability.
In (a) and (b) we show the evolution of pathogen virulence over time under different transmission distributions. In (a) we show the deterministic simulations and (b) we show the stochastic simulations. In (c) we show the proportion of susceptible individuals in each transmission class, ci and (d) the proportion of infected individuals in each transmission class. All proportions are shown at the evolutionary stable level of pathogen virulence, , in the deterministic simulations. The mean level of transmission,
, is also shown for each distribution. The simulations are for a function (
) that shows an increase in vulnerability for hosts that have high transmission, as in Fig 4. Other parameters are taken from Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s008
(EPS)
S8 Fig. The evolution of pathogen virulence over time under different transmission distributions, using the model framework detailed in the manuscript, with
.
The mean level of transmission across all simulations, , is shown for each distribution (in blue for k = 0.2, and orange for k = 1 and k = 10). The figure directly relates to that of Fig 2, but with lower levels of pathogen virulence and transmission:
. All other parameters are taken from Fig 2.
https://doi.org/10.1371/journal.pcbi.1013517.s009
(EPS)
S9 Fig. The evolution of virulence for the SI model when contacts are linked to host survival.
(a) The evolved level of pathogen virulence, , for different transmission distributions for the host (characterised by changes in k), and with rates of host natural death, d(ci), linked to host transmission level, ci. (b) The function d(ci) where the host death rate decreases with increases in host transmission level (increased connectivity). The figure directly relates to that of Fig 3, but with lower levels of pathogen virulence and transmission:
. All other parameters are taken from Fig 3.
https://doi.org/10.1371/journal.pcbi.1013517.s010
(EPS)
References
- 1. Gavier-Widén D, Ståhl K, Dixon L. No hasty solutions for African swine fever. Science. 2020;367(6478):622–4. pmid:32029612
- 2. Lycett SJ, Duchatel F, Digard P. A brief history of bird flu. Philos Trans R Soc Lond B Biol Sci. 2019;374(1775):20180257. pmid:31056053
- 3. Marani M, Katul GG, Pan WK, Parolari AJ. Intensity and frequency of extreme novel epidemics. Proc Natl Acad Sci U S A. 2021;118(35):e2105482118. pmid:34426498
- 4. Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400(10359):1224–80. pmid:36115368
- 5. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347(6227):aaa4339. pmid:25766240
- 6. Metcalf CJE, Edmunds WJ, Lessler J. Six challenges in modelling for public health policy. Epidemics. 2015;10:93–6. pmid:25843392
- 7. Althouse BM, Wenger EA, Miller JC, Scarpino SV, Allard A, Hébert-Dufresne L, et al. Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLoS Biol. 2020;18(11):e3000897. pmid:33180773
- 8. Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proc Natl Acad Sci U S A. 2020;117(36):22430–5. pmid:32820074
- 9. Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371(6526):eabe2424. pmid:33234698
- 10. Galvani AP, May RM. Epidemiology: dimensions of superspreading. Nature. 2005;438(7066):293–5. pmid:16292292
- 11. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355–9. pmid:16292310
- 12. Gandon S, Hochberg ME, Holt RD, Day T. What limits the evolutionary emergence of pathogens?. Philos Trans R Soc Lond B Biol Sci. 2013;368(1610):20120086. pmid:23209168
- 13. Leventhal GE, Hill AL, Nowak MA, Bonhoeffer S. Evolution and emergence of infectious diseases in theoretical and real-world networks. Nat Commun. 2015;6:6101. pmid:25592476
- 14. Yates A, Antia R, Regoes RR. How do pathogen evolution and host heterogeneity interact in disease emergence?. Proc Biol Sci. 2006;273(1605):3075–83. pmid:17015347
- 15. Cressler CE, McLEOD DV, Rozins C, VAN DEN Hoogen J, Day T. The adaptive evolution of virulence: a review of theoretical predictions and empirical tests. Parasitology. 2016;143(7):915–30. pmid:26302775
- 16. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3. pmid:18288193
- 17. Alizon S, Hurford A, Mideo N, Van Baalen M. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J Evol Biol. 2009;22(2):245–59. pmid:19196383
- 18. Anderson RM, May RM. Coevolution of hosts and parasites. Parasitology. 1982;85 (Pt 2):411–26. pmid:6755367
- 19. Frank SA. Models of parasite virulence. Q Rev Biol. 1996;71(1):37–78. pmid:8919665
- 20. Morozov AY, Adamson MW. Evolution of virulence driven by predator-prey interaction: possible consequences for population dynamics. J Theor Biol. 2011;276(1):181–91. pmid:21320512
- 21. Day T, Graham AL, Read AF. Evolution of parasite virulence when host responses cause disease. Proc Biol Sci. 2007;274(1626):2685–92. pmid:17711836
- 22. O’Neill X, White A, Boots M. The evolution of parasite virulence under targeted culling and harvesting in wildlife and livestock. Evol Appl. 2023;16(10):1697–707. pmid:38020874
- 23. Bartlett LJ, Boots M. The central role of host reproduction in determining the evolution of virulence in spatially structured populations. J Theor Biol. 2021;523:110717. pmid:33862089
- 24. Boots M, Sasaki A. “Small worlds” and the evolution of virulence: infection occurs locally and at a distance. Proc Biol Sci. 1999;266(1432):1933–8. pmid:10584335
- 25. Kamo M, Sasaki A, Boots M. The role of trade-off shapes in the evolution of parasites in spatial host populations: an approximate analytical approach. J Theor Biol. 2007;244(4):588–96. pmid:17055535
- 26. Lion S, Gandon S. Evolution of spatially structured host-parasite interactions. J Evol Biol. 2015;28(1):10–28. pmid:25439133
- 27. Regoes RR, Nowak MA, Bonhoeffer S. Evolution of virulence in a heterogeneous host population. Evolution. 2000;54(1):64–71. pmid:10937184
- 28. White PS, Choi A, Pandey R, Menezes A, Penley M, Gibson AK, et al. Host heterogeneity mitigates virulence evolution. Biol Lett. 2020;16(1):20190744. pmid:31992149
- 29. Williams PD, Day T. Epidemiological and evolutionary consequences of targeted vaccination. Mol Ecol. 2008;17(1):485–99. pmid:18173510
- 30. Bull JJ, Antia R. Which “imperfect vaccines” encourage the evolution of higher virulence?. Evol Med Public Health. 2022;10(1):202–13. pmid:35539897
- 31. Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414(6865):751–6. pmid:11742400
- 32. Bonds MH, Keenan DC, Leidner AJ, Rohani P. Higher disease prevalence can induce greater sociality: a game theoretic coevolutionary model. Evolution. 2005;59(9):1859–66. pmid:16261724
- 33. Ashby B, Farine DR. Social information use shapes the coevolution of sociality and virulence. Evolution. 2022;76(6):1153–69. pmid:35420704
- 34. Nielsen BF, Sneppen K, Simonsen L. The counterintuitive implications of superspreading diseases. Nat Commun. 2023;14(1):6954. pmid:37907452
- 35. VanderWaal KL, Ezenwa VO. Heterogeneity in pathogen transmission: mechanisms and methodology. Functional Ecology. 2016;30(10):1606–22.
- 36.
Van Baalen M. Contact networks and the evolution of virulence. Adaptive dynamics of infectious diseases: in pursuit of virulence management. Cambridge, UK: Cambridge University Press. 2002. p. 85–103.
- 37. Anderson RM, May RM. Population biology of infectious diseases: Part I. Nature. 1979;280(5721):361–7. pmid:460412
- 38.
Keeling M., Rohani P. Modeling infectious diseases in humans and animals. Princeton University Press; 2008.
- 39. Boots M, Bowers RG. Three mechanisms of host resistance to microparasites-avoidance, recovery and tolerance-show different evolutionary dynamics. J Theor Biol. 1999;201(1):13–23. pmid:10534432
- 40. Roy BA, Kirchner JW. Evolutionary dynamics of pathogen resistance and tolerance. Evolution. 2000;54(1):51–63. pmid:10937183
- 41. Miller MR, White A, Boots M. The evolution of host resistance: tolerance and control as distinct strategies. J Theor Biol. 2005;236(2):198–207. pmid:16005309
- 42. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012;335(6071):936–41. pmid:22363001
- 43. Gupta S. Darwin review: the evolution of virulence in human pathogens. Proc Biol Sci. 2024;291(2016):20232043. pmid:38320607
- 44. McCallum H, Dobson A. Detecting disease and parasite threats to endangered species and ecosystems. Trends Ecol Evol. 1995;10(5):190–4. pmid:21237000
- 45. McCallum H. Disease and the dynamics of extinction. Philos Trans R Soc Lond B Biol Sci. 2012;367(1604):2828–39. pmid:22966138
- 46. Geritz S, Kisdi E, Meszéna G, Metz J. Evolutionary singular strategies and the adaptive growth and branching of the evolutionary tree. Evol Ecol. 1998;12:35–57.
- 47.
Metz J, Geritz S, Meszena G, Jacobs F, Van HeerWaarden J. Adaptive dynamics: a geometric study of the consequences of nearly faithful reproduction. In Van Strien S, Verduyn Lunel S (eds.) Stochastic and Spatial Structures of Dynamical Systems. North-Holland: 1996; p. 183–231.
- 48. Bowers RG, Hoyle A, White A, Boots M. The geometric theory of adaptive evolution: trade-off and invasion plots. J Theor Biol. 2005;233(3):363–77. pmid:15652146
- 49. White A, Greenman J, Benton T, Boots M. Evolutionary behaviour in ecological systems with trade-offs and non-equilibrium population dynamics. Evolutionary Ecology Research. 2006;8:387–98.
- 50. Gillespie DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem. 1977;81(25):2340–61.
- 51.
Renshaw E. Modelling biological populations in space and time. Cambridge University Press; 1993.
- 52. Meszéna G, Kisdi É, Dieckmann U, Geritz SAH, Metz JAJ. Evolutionary optimisation models and matrix games in the unified perspective of adaptive dynamics. Selection. 2002;2(1–2):193–220.
- 53. Snijders L, Krause S, Tump AN, Breuker M, Ortiz C, Rizzi S, et al. Causal evidence for the adaptive benefits of social foraging in the wild. Commun Biol. 2021;4(1):94. pmid:33473153
- 54. Valone TJ. From eavesdropping on performance to copying the behavior of others: a review of public information use. Behav Ecol Sociobiol. 2007;62(1):1–14.
- 55. Miller MR, White A, Boots M. The evolution of parasites in response to tolerance in their hosts: the good, the bad, and apparent commensalism. Evolution. 2006;60(5):945–56. pmid:16817535
- 56.
Leavitt J. Typhoid Mary: captive to the public’s health. Beacon Press; 2014.
- 57. Lanfear R, Kokko H, Eyre-Walker A. Population size and the rate of evolution. Trends Ecol Evol. 2014;29(1):33–41. pmid:24148292
- 58. Read JM, Keeling MJ. Disease evolution on networks: the role of contact structure. Proc Biol Sci. 2003;270(1516):699–708. pmid:12713743
- 59. Best A, White A, Boots M. The coevolutionary implications of host tolerance. Evolution. 2014;68(5):1426–35. pmid:24475902
- 60. Best A, White A, Boots M. Maintenance of host variation in tolerance to pathogens and parasites. Proc Natl Acad Sci U S A. 2008;105(52):20786–91. pmid:19088200
- 61. Illingworth C, Hamilton W, Warne B, Routledge M, Popay A. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections. eLife. 2021;10:e67308.
- 62. Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, et al. The importance of heterogeneity to the epidemiology of tuberculosis. Clin Infect Dis. 2019;69(1):159–66. pmid:30383204
- 63. Day T. Parasite transmission modes and the evolution of virulence. Evolution. 2001;55(12):2389–400. pmid:11831655
- 64. Wright J, Stone RE, Brown N. Communal roosts as structured information centres in the raven, Corvus corax. Journal of Animal Ecology. 2003;72(6):1003–14.
- 65. McComb K, Moss C, Durant SM, Baker L, Sayialel S. Matriarchs as repositories of social knowledge in African elephants. Science. 2001;292(5516):491–4. pmid:11313492
- 66. Streicker DG, Winternitz JC, Satterfield DA, Condori-Condori RE, Broos A, Tello C, et al. Host-pathogen evolutionary signatures reveal dynamics and future invasions of vampire bat rabies. Proc Natl Acad Sci U S A. 2016;113(39):10926–31. pmid:27621441
- 67. Cross PC, Heisey DM, Bowers JA, Hay CT, Wolhuter J, Buss P, et al. Disease, predation and demography: assessing the impacts of bovine tuberculosis on African buffalo by monitoring at individual and population levels. Journal of Applied Ecology. 2009;46(2):467–75.
- 68. Drewe JA. Who infects whom? Social networks and tuberculosis transmission in wild meerkats. Proc Biol Sci. 2010;277(1681):633–42. pmid:19889705